Navigation Links
Cogdell Spencer Inc. Announces Increased Earnings in 2008, Cautious Outlook for 2009
Date:2/25/2009

= ======== ======== Net loss per share - basic and diluted $(0.06) $(0.11) $(0.37) $(0.57) ======== ========= ======== ======== Weighted average common shares - basic and diluted (1) 17,557 11,935 15,770 11,056 ======== ========= ======== ======== (1) 7 and 13 shares of unvested restricted common stock are anti-dilutive due to the net loss for the three months ended December 31, 2008 and 2007, respectively. 9 and 17 shares of unvested restricted common stock are anti-dilutive due to the net loss for the year ended December 31, 2008 and 2007, respectively. 

                               Cogdell Spencer Inc.
                            Business Segment Reporting
                                  (In thousands)
                                   (unaudited)

                                        Design-Build
    Three months ended       Property        and       Unallocated
     December 31, 2008:     Operations   Development     and Other    Total
                            ----------  -------------  ------------  -------

    Revenues:
      Rental revenue           $20,177             $-            $-  $20,177
      Design-Build
       contract revenue and
       other sales                   -         78,726             -   78,726
      Property management
       and other fees              935              -             -      935
      Development
       management and other
       income                        -            134             -      134
                            ----------  -------------  ------------  -------
        Total revenues          21,112         78,860             -   99,972

    Operating expenses:
      Property operating
       and management            7,972              
'/>"/>
SOURCE  Cogdell Spencer Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 

Related medicine news :

1. Cogdell Spencer Inc. Acquires Summit Professional Plaza I and II in Brunswick, Georgia
2. Cogdell Spencer Inc. Reports Third Quarter 2007 Financial Results
3. Cogdell Spencer Announces a $100 Million Development at St. Lukes Riverside Outpatient Campus In Bethlehem, Pennsylvania
4. Cogdell Spencer Inc. Announces Merger with Marshall Erdman and Associates
5. Cogdell Spencer Inc. Announces the Closing of the Marshall Erdman and Associates Merger
6. Cogdell Spencer Inc. Announces First Quarter Earnings Release and Conference Call Notice
7. Cogdell Spencer Inc. Reports First Quarter 2008 Financial Results
8. Cogdell Spencer Announces First Synergy Project in Pensacola, Florida
9. Cogdell Spencer Inc. Reports Third Quarter 2008 Financial Results
10. Cogdell Spencer Inc. Declares Quarterly Dividend and Outlines 2009 Business Strategy
11. Cogdell Memorial Hospital Partners with Healthcare Management Systems
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:New Executive Leadership and CEO Announced for BiPar Sciences 2ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 2ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 3ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 4Federal Judge Rejects GlaxoSmithKline's Claims of Privilege 2Tianyin Pharmaceutical Co Inc Provides Fiscal 2010 Guidance 49332 1Tianyin Pharmaceutical Co Inc Provides Fiscal 2010 Guidance 49332 2Tianyin Pharmaceutical Co Inc Provides Fiscal 2010 Guidance 49332 3Tianyin Pharmaceutical Co Inc Provides Fiscal 2010 Guidance 49332 4Tianyin Pharmaceutical Co Inc Provides Fiscal 2010 Guidance 49332 5Arena Pharmaceuticals to Present at the Piper Jaffray Fourth Annual Europe Conference 49329 1Arena Pharmaceuticals to Present at the Piper Jaffray Fourth Annual Europe Conference 49329 2Arena Pharmaceuticals to Present at the Piper Jaffray Fourth Annual Europe Conference 49329 3HLTH Corporation and WebMD Health Corp Announce Agreement to Merge 49326 1HLTH Corporation and WebMD Health Corp Announce Agreement to Merge 49326 2HLTH Corporation and WebMD Health Corp Announce Agreement to Merge 49326 3HLTH Corporation and WebMD Health Corp Announce Agreement to Merge 49326 4HLTH Corporation and WebMD Health Corp Announce Agreement to Merge 49326 5